Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
318 hedge funds and large institutions have $6.84B invested in Abiomed Inc in 2017 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 119 increasing their positions, 105 reducing their positions, and 27 closing their positions.
78% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 27
52% more call options, than puts
Call options by funds: $29.4M | Put options by funds: $19.3M
19% more capital invested
Capital invested by funds: $5.73B → $6.84B (+$1.1B)
13% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 105
5% more funds holding
Funds holding: 303 → 318 (+15)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$82.2M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$52.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$41M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$36.6M |
| 5 |
Renaissance Technologies
New York
|
+$29.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$123M |
| 2 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$76.1M |
| 3 |
Primecap Management
Pasadena,
California
|
-$32.7M |
| 4 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$30.1M |
| 5 |
D.E. Shaw & Co
New York
|
-$21.4M |
ABMD Hedge Fund Activity: Q3 2017 in Review
318 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2017, worth a combined $6.84B — up 19% from $5.73B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new ABMD positions and 27 closed out — a net gain of 21 holders — while 119 added to existing stakes and 105 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $82.2M. The largest seller was Wellington Management Group, cutting an estimated $123M.
- 318 institutional investors held Abiomed Inc (ABMD) as of Q3 2017, up from 303 in Q2 2017.
- Funds reported $6.84B of Abiomed Inc stock for Q3 2017, up 19% quarter-over-quarter.
- 48 funds opened new Abiomed Inc positions in Q3 2017 and 27 closed out, a net change of +21 holders.
- The largest Abiomed Inc buyer in Q3 2017 was Janus Henderson Group, an estimated $82.2M added.
- The largest Abiomed Inc seller in Q3 2017 was Wellington Management Group, an estimated $123M sold.
Based on aggregated 13F filings for Q3 2017.